Galactooligosaccharides Market CAGR at 7.1% by 2034

Overview

New York, NY – July 04, 2025 – The Global Galactooligosaccharides (GOS) Market is experiencing strong growth, expected to rise from USD 845.1 million in 2024 to USD 1678.0 million by 2034, with a steady CAGR of 7.1% during the 2025–2034 forecast period. Animal-based GOS led the market in 2024, commanding a 51.3% share of the global Galactooligosaccharides (GOS) market.

This dominance is driven by the high lactose content in cow’s milk, the primary substrate for enzymatic GOS production. Powdered GOS captured a 67.4% share of the global GOS market, driven by its stability, extended shelf life, and ease of transport and storage compared to liquid forms. The Prebiotic Function dominated in 2024, holding a 73.1% share of the global GOS market, propelled by rising awareness of gut health and its role in fostering beneficial gut bacteria like bifidobacteria and lactobacilli.

Key Takeaways

• Galactooligosaccharides Market size is expected to be worth around USD 1678.0 Million by 2034, from USD 845.1 Million in 2024, growing at a CAGR of 7.1%.
• Animals held a dominant market position, capturing more than a 51.3% share of the global Galactooligosaccharides (GOS) market.
• Powder held a dominant market position, capturing more than a 67.4% share of the global Galactooligosaccharides (GOS) market.
• Prebiotics held a dominant market position, capturing more than a 73.1% share of the global Galactooligosaccharides (GOS) market.
• Food and beverage held a dominant market position, capturing more than a 59.5% share of the global Galactooligosaccharides (GOS) market.
• North America emerged as the leading regional market for Galactooligosaccharides (GOS), capturing approximately 43.8% of the global market and driving revenues of about USD 370.1 million.

How Growth is Impacting the Economy

The GOS market’s robust growth significantly impacts the global economy by fostering innovation and job creation in the food, beverage, and supplement industries. The projected rise from USD 845.1 million to USD 1678.0 million by 2034 fuels investment in production facilities, particularly in North America and Europe, where dairy infrastructure supports animal-based GOS.

This growth drives demand for skilled labor in manufacturing and R&D, boosting local economies. Increased consumer spending on health-focused products like infant formula and dietary supplements stimulates the retail and e-commerce sectors. However, competition from alternative prebiotics like isomalto-oligosaccharides may challenge market expansion, necessitating strategic differentiation to sustain economic contributions.

➤ Curious about the content? Explore a sample copy of this report – https://market.us/report/global-galactooligosaccharides-market/request-sample/

Strategies for Businesses

Businesses in the GOS market should focus on innovation, developing plant-based GOS to cater to lactose-intolerant consumers and align with clean-label trends. Strategic partnerships with infant formula and dairy manufacturers can expand market reach. Investing in R&D to enhance GOS purity and functionality, like FrieslandCampina’s Biotis GOS-OP, can differentiate products. Leveraging e-commerce platforms, given their growing popularity in healthcare, ensures broader consumer access. Additionally, emphasizing sustainable sourcing and transparent marketing can attract health-conscious consumers, strengthening brand loyalty and market share in this competitive, health-driven sector.

Report Scope

➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=150565

Key Market Segments

By Source

• Animal-based GOS led the market in 2024, commanding a 51.3% share of the global Galactooligosaccharides (GOS) market. This dominance is driven by the high lactose content in cow’s milk, the primary substrate for enzymatic GOS production. Bovine dairy’s accessibility, cost-effectiveness, and consistent quality make it the preferred source. Robust dairy processing infrastructure in North America and Europe further strengthens animal-based GOS, which continues to outperform plant-based or synthetic alternatives in volume and application diversity across infant nutrition, dietary supplements, and functional foods through early 2025.

By Form

• In 2024, Powdered GOS captured a 67.4% share of the global GOS market, driven by its stability, extended shelf life, and ease of transport and storage compared to liquid forms. Its versatility in applications like infant formula, nutritional supplements, and dairy products, where precise dosing and dry blending are critical, fuels its dominance. Manufacturers favor powder for its logistical advantages in global trade. Demand for powdered GOS remains strong in 2024 and early 2025, particularly in Europe and Asia-Pacific, sustaining its lead in volume and revenue.

By Function Type

• The Prebiotic Function dominated in 2024, holding a 73.1% share of the global GOS market, propelled by rising awareness of gut health and its role in fostering beneficial gut bacteria like bifidobacteria and lactobacilli. GOS’s widespread use in infant formulas, functional foods, and dietary supplements drives demand. The growing popularity of clean-label, gut-friendly products in developed and emerging markets has solidified the prebiotic function’s position as the primary driver of GOS applications in food and healthcare sectors through early 2025.

By Application

• Food and beverage applications led the GOS market in 2024, capturing a 59.5% share, fueled by demand for functional ingredients in everyday diets. GOS is increasingly incorporated into dairy products, baked goods, and health drinks for its gut health benefits without compromising taste or texture. Its seamless integration into various food matrices makes it a preferred choice for manufacturers. The trend of fortifying foods with prebiotics continues to grow in North America, Europe, and Asia, reinforcing the dominance of food and beverage applications into 2025.

Regional Analysis

In 2024, North America led the global Galactooligosaccharides (GOS) market, holding a 43.8% share and generating USD 370.1 million in revenue. This leadership stems from a health-conscious consumer base and advanced food processing infrastructure. Regulatory support has been pivotal. The U.S. Food and Drug Administration and Health Canada have approved GOS as safe for use in food and beverages, including infant formula, under dietary fiber classifications. Combined with dietary guidelines promoting fiber and prebiotic consumption, this has driven widespread adoption of GOS in various product formulations.

Recent Developments

1. Abbott Laboratories

• Abbott has been advancing its pediatric nutrition portfolio, incorporating GOS into infant formula to support gut health and immunity. Their Similac Pro-Advance and Pro-Sensitive formulas now include GOS alongside 2’-FL HMO (human milk oligosaccharide) to mimic breast milk benefits. Research highlights GOS’s role in promoting beneficial gut bacteria in infants. Abbott continues to invest in clinical studies to validate these benefits.

2. Beneo-Orafti

• Beneo, through its Orafti brand, has expanded its prebiotic offerings, including GOS, to support digestive and immune health. Recent innovations focus on combining GOS with inulin for synergistic gut microbiota effects. Beneo emphasizes clean-label, non-GMO GOS for infant nutrition and functional foods. Their research highlights GOS’s ability to enhance mineral absorption and gut barrier function.

3. Clasado

• Clasado Biosciences has been enhancing its GOS-based prebiotics, particularly its Bimuno product line. Recent studies demonstrate Bimuno GOS’s efficacy in reducing stress-related gut discomfort and improving cognitive function via the gut-brain axis. The company is also exploring GOS applications in mental health and immunity. Clasado continues to expand its clinical evidence supporting GOS benefits.

4. Danone

• Danone has integrated GOS into its early-life nutrition products, such as Aptamil and Nutrilon infant formulas, to support gut microbiota development. Recent research focuses on combining GOS with fructooligosaccharides (FOS) for optimal prebiotic effects. Danone also explores GOS in dairy products for adults, promoting digestive health. Their Nutricia division continues to invest in microbiome science.

5. DuPont de Nemours, Inc.

• DuPont’s Nutrition & Biosciences division (now part of IFF) offers GOS under its prebiotic portfolio. Recent developments include GOS-enriched solutions for infant nutrition and functional foods. DuPont highlights GOS’s role in enhancing bifidobacteria growth and gut health. Their research focuses on optimizing GOS production for better efficacy and cost-efficiency.

Conclusion

The GOS market’s growth reflects increasing consumer focus on gut health and nutrition, driving economic benefits through innovation and job creation. While challenges like competition from alternative prebiotics exist, strategic investments in plant-based products and e-commerce can sustain momentum. Businesses leveraging R&D and consumer trends will thrive. The market’s alignment with health and wellness ensures its relevance, promising continued economic and health benefits globally.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF